Tempest Therapeutics (TPST) EBITDA Margin (2015 - 2018)
Tempest Therapeutics (TPST) posted EBITDA Margin of -14010.91% for Q3 2018, up 2071.23 percentage points from -16082.14% a year earlier but down 8102.27 percentage points from the prior quarter.
Tempest Therapeutics (TPST) EBITDA Margin (2015 - 2018) Analysis & Trends
For the trailing twelve months through Sep 30, 2018, EBITDA Margin at Tempest Therapeutics was -19937.07%, down 709.30 percentage points year-over-year; for FY2017, it came in at -28025.76%, down 15962.36 percentage points from FY2016.
- In prior years, Tempest Therapeutics' EBITDA Margin was -12063.40% in FY2016 (+13459.70 pp) and -25523.10% in FY2015.
- Quarterly EBITDA Margin has run from a low of -110573.33% in Q1 2015 to a high of -5908.64% in Q2 2018 over five years.
- On a year-over-year basis, EBITDA Margin has increased in each of the last three quarters, with an average year-over-year change of -3333.34 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q1 2016, with a gain of 96234.29 percentage points; the weakest was Q4 2017, with a drop of 28229.41 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -5908.64% (Q2 2018), -6056.72% (Q1 2018) and -46225.27% (Q4 2017).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Tempest Therapeutics | 4.09 Mn | -26.23 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | -14,010.91% |
| Jun 30, 2018 | -5,908.64% |
| Mar 31, 2018 | -6,056.72% |
| Dec 31, 2017 | -46,225.27% |
| Sep 30, 2017 | -16,082.14% |
| Jun 30, 2017 | -20,750.00% |
| Mar 31, 2017 | -22,360.32% |
| Dec 31, 2016 | -17,995.87% |
| Sep 30, 2016 | -9,321.83% |
| Jun 30, 2016 | -9,333.86% |
| Mar 31, 2016 | -14,339.04% |
| Dec 31, 2015 | -12,540.13% |
| Sep 30, 2015 | -23,296.00% |
| Jun 30, 2015 | -56,580.00% |
| Mar 31, 2015 | -110,573.33% |
Tempest Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TPST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TPST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TPST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();